

|
Email:
|
veronika.benetinova@upjs.sk | |
|
Homepage:
|
https://www.upjs.sk/LF/zamestnanec/veronika.benetinova | |
|
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
|
Department:
|
CKPV
-
Center of Clinical and Preclinical Research MEDIPARK
|
|
|
Office:
|
MB6O18 | |
|
Phone:
|
+421 55 234 3265 | |
|
ORCID ID:
|
0000-0001-9523-8203 |
|
Selected publications
|
|
Štofilová J, Benetinová V, Bertková I, Hanzelová Z, Kamlárová A, Kvaková M. Probiotic drug interactions in ulcerative colitis: a microbiota and metabolite perspective. Front Microbiol. 2026 Sep 16;17:1944134. doi: 10.3389/fmicb.2026.1944134. PMID: 42819218; PMCID: PMC13625272. |
|
Hijová E, Bertková I, Benetinová V. Gut Microbiota as an Innovative Therapeutic Target in Cardiovascular Diseases from a Metabolic and Inflammatory Perspective. Biomedicines. 2026 Jun 1;14(6):1267. doi: 10.3390/biomedicines14061267. PMID: 42351694; PMCID: PMC13296562. |
|
Kvakova M, Kamlarova A, Stofilova J, Benetinova V, Bertkova I. Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy. World J Gastroenterol. 2022 Jul 21;28(27):3370-3382. doi: 10.3748/wjg.v28.i27.3370. PMID: 36158273; PMCID: PMC9346452. |
|
Vybrané mediátory alergického zápalu ako potenciálne biomarkery alergických respiračných ochorení. V. Benetinová, M. Kvaková, I. Bertková. In: Životné podmienky a zdravie : zborník vedeckých prác. - Bratislava Univerzita Komenského v Bratislave, 2021. - ISBN 9788022351737. - S. 245-254. |
|
Stanovenie biomarkerov alergického zápalu pre hodnotenie jednotnej choroby dýchacích ciest. Veronika Benetinová, Norbert Lukán, Izabela Bertková. Martinské dni imunológie (19. : 15.-17.09.2021 : Martin, Slovensko); In: Klinická imunológia a alergológia. - ISSN 1335-0013. - Roč. 31, č. 3 (2021), s. 40-40. |
|
Selected projects
|
|
PERBIOKARDIO (ITMS21+ NFP401101C030) - INNOVATIVE APPROACH IN GUT MICROBIOME RESEARCH AND PERSONALIZED PROBIOTICS FOR CARDIOVASCULAR DISEASES - researcher The main objective of the PERBIOKARDIO project is the dedicated research and development of probiotics with defined antiinflammatory and hypolipidemic properties, and the characterization of microbial, metabolic, and immune changes in CVD patients, for the future personalized prevention and therapy of CVD using targeted probiotics. |
|
APVV-23-0354 A personalized approach of the selection and application of effective probiotics and synbiotics in the management of obesity – researcher The aim of the project is to conduct specialized research and select probiotic Lactobacillus strains with defined anti-inflammatory and hypolipidemic properties for their future personalized application in patients with obesity. |
|
Drive4SIFood (ITMS2014+: 313011V336) Demand-driven research for sustainable and innovative foods – researcher The goal of the project is to expand knowledge and improve understanding within the food system through scientific research to develop high-quality, safe, and innovative foods, as well as their subsequent environmental and energetic processing. |
|
VEGA 1/0253/25 Innovative approach in therapy of inflammatory bowel diseases - targeted probiotics and synbiotics – researcher The aim of the project is advanced preclinical analyses of the beneficial effect of new probiotic strains of Limosilactobacillus fermentum together with the selection of natural prebiotics specifically designed for biomedical use in IBD therapy. |
|
VEGA 1/0232/25 Preclinical molecular-biological research on the effect of probiotics and synbiotics based on Limosilactobacillus fermentum on targeted improvement of intestinal barrier function- researcher The aim of this project is advanced molecular preclinical analyses of clinically promising probiotic strains of Limosilactobacillus fermentum along with the selection of suitable prebiotics enhancing their efficacy and targeted validation of their synbiotic effect on the disrupted IB using complex in vitro models. |
